142 related articles for article (PubMed ID: 25368277)
1. Radiotherapy for stage I/II follicular lymphoma (FL): is it time for a re-appraisal?
Mondello P; Steiner N; Wasle I; Pitini V; Mian M
Anticancer Res; 2014 Nov; 34(11):6701-4. PubMed ID: 25368277
[TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03.
MacManus M; Fisher R; Roos D; O'Brien P; Macann A; Davis S; Tsang R; Christie D; McClure B; Joseph D; Jayamohan J; Seymour JF
J Clin Oncol; 2018 Oct; 36(29):2918-2925. PubMed ID: 29975623
[TBL] [Abstract][Full Text] [Related]
3. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
4. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
[TBL] [Abstract][Full Text] [Related]
5. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
Găman AM
Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
[TBL] [Abstract][Full Text] [Related]
7. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
Mac Manus MP; Hoppe RT
J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
[TBL] [Abstract][Full Text] [Related]
8. [Follicle centre lymphoma: treatment results for stage I and II].
Neumann H; Blanck H; Koch R; Fiedler S; Lesche A; Herrmann T
Strahlenther Onkol; 2003 Dec; 179(12):840-6. PubMed ID: 14652673
[TBL] [Abstract][Full Text] [Related]
9. Outcomes after involved-field radiation therapy (IFRT) with or without rituximab in patients with early-stage low-grade non-Hodgkin lymphoma (NHL) staged with CT and PET.
Lukens JN; Nasta SD; Fram B; Glatstein E; Plastaras JP
Am J Clin Oncol; 2014 Feb; 37(1):35-40. PubMed ID: 22992623
[TBL] [Abstract][Full Text] [Related]
10. Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy.
Campbell BA; Connors JM; Gascoyne RD; Morris WJ; Pickles T; Sehn LH
Cancer; 2012 Sep; 118(17):4156-65. PubMed ID: 22252721
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation.
Guckenberger M; Alexandrow N; Flentje M
Radiat Oncol; 2012 Jun; 7():103. PubMed ID: 22726938
[TBL] [Abstract][Full Text] [Related]
12. R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.
Federico M; Luminari S; Dondi A; Tucci A; Vitolo U; Rigacci L; Di Raimondo F; Carella AM; Pulsoni A; Merli F; Arcaini L; Angrilli F; Stelitano C; Gaidano G; Dell'olio M; Marcheselli L; Franco V; Galimberti S; Sacchi S; Brugiatelli M
J Clin Oncol; 2013 Apr; 31(12):1506-13. PubMed ID: 23530110
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
Leuk Lymphoma; 2015; 56(8):2350-6. PubMed ID: 25426666
[TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
Bentur OS; Gurion R; Gafter-Gvili A; Gatt M; Shvidel L; Horowitz NA; Ram R; Herishanu Y; Sarid N; Paltiel O; Ganzel C; Kreiniz N; Dally N; Gutwein O; Raanani P; Avivi I; Perry C
Leuk Lymphoma; 2018 May; 59(5):1163-1171. PubMed ID: 28901817
[TBL] [Abstract][Full Text] [Related]
16. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
Rosenbluth BD; Yahalom J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
[TBL] [Abstract][Full Text] [Related]
17. Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy.
MacDermed D; Thurber L; George TI; Hoppe RT; Le QT
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):788-95. PubMed ID: 15183482
[TBL] [Abstract][Full Text] [Related]
18. The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment.
Sancho JM; García O; Mercadal S; Pomares H; Fernández-Alvarez R; González-Barca E; Tapia G; González-García E; Moreno M; Domingo-Domènech E; Sorigué M; Navarro JT; Motlló C; Fernández-de-Sevilla A; Feliu E; Ribera JM
Leuk Res; 2015 Aug; 39(8):853-8. PubMed ID: 26122511
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.
Cencini E; Puccini B; Rigacci L; Fabbri A; Kovalchuk S; Mannelli L; Benelli G; Carfagno T; Simontacchi G; Bocchia M; Bosi A
Leuk Lymphoma; 2018 Jun; 59(6):1420-1426. PubMed ID: 28994343
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.
Zinzani PL; Pellegrini C; Broccoli A; Casadei B; Argnani L; Pileri S
Am J Hematol; 2013 Nov; 88(11):E273-6. PubMed ID: 23843267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
